Innovent Biologics showcases promising preclinical data at AACR 2024

businessnewstoday- April 8, 2024 0

In a significant development for cancer research, Innovent Biologics, Inc. (HKEX: 01801), a leading biopharmaceutical company renowned for its innovative medicines in oncology, cardiovascular and ... Read More

AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development

businessnewstoday- March 19, 2024 0

In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of ... Read More

Bristol Myers Squibb and 2seventy bio’s Abecma gets positive FDA committee vote for multiple myeloma

businessnewstoday- March 18, 2024 0

In a significant development in the healthcare industry, Bristol Myers Squibb (NYSE: BMY) and 2seventy bio, Inc. (Nasdaq: TSVT) have announced a favorable vote by ... Read More

FDA approves BeiGene’s TEVIMBRA for esophageal cancer treatment

businessnewstoday- March 18, 2024 0

In a notable advancement in the oncology sector, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a globally recognized oncology company, has received approval from ... Read More

Zephyr AI announces $111m Series A to advance AI in precision medicine

businessnewstoday- March 14, 2024 0

Zephyr AI, Inc., a pioneering healthcare technology company committed to enhancing precision medicine through fast and explainable Artificial Intelligence (AI) solutions, has successfully closed a ... Read More

Eris Lifesciences acquires Biocon Biologics’ branded formulation business for Rs 1,242cr

businessnewstoday- March 14, 2024 0

In a strategic move that reshapes the landscape of India's injectables market, Eris Lifesciences Ltd., a leading player in the branded formulations sector, has announced ... Read More

Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible

businessnewstoday- March 13, 2024 0

In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name IBYRA, a pioneering PARP inhibitor designed to ... Read More

CureMatch, Spesana forge partnership to revolutionize precision medicine

businessnewstoday- March 11, 2024 0

In a groundbreaking development for the healthcare industry, CureMatch and Spesana have announced a strategic partnership aimed at advancing precision medicine and transforming patient care ... Read More

Immune-Onc Therapeutics gets FDA orphan drug status for IO-202 in CMML

businessnewstoday- February 22, 2024 0

Immune-Onc Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies in immunology and oncology, has achieved a significant milestone with the ... Read More

Kinnate Biopharma agrees to merger with XOMA, boosting shareholder value and advancing cancer research

businessnewstoday- February 18, 2024 0

Kinnate Biopharma Inc. (Nasdaq: KNTE), a leading clinical-stage precision oncology company, has announced a definitive merger agreement with XOMA Corporation, setting the stage for a ... Read More